BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Boehringer Ingelheim, Roche Forge Partnership for Inflammatory Bowel Diseases December 18, 2017 Delcath Systems Announces Adjournment Of Annual Meeting Meeting Scheduled To Reconvene On June 16 June 5, 2017 3 Biotechs That Could be Taken Out This Quarter March 30, 2017
Delcath Systems Announces Adjournment Of Annual Meeting Meeting Scheduled To Reconvene On June 16 June 5, 2017
